Itron, Inc. (NASDAQ:ITRI) Receives “Buy” Rating from Needham & Company LLC

Itron, Inc. (NASDAQ:ITRI)‘s stock had its “buy” rating reiterated by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Thursday. They presently have a $84.00 price target on the scientific and technical instruments company’s stock, up from their prior price target of $74.00. Needham & Company LLC’s price target points to a potential upside of 16.59% from the stock’s previous close.

ITRI has been the subject of several other research reports. BidaskClub cut Itron from a “strong-buy” rating to a “buy” rating in a report on Thursday, July 27th. Cowen and Company set a $74.00 price objective on Itron and gave the company a “hold” rating in a report on Thursday. Canaccord Genuity restated a “buy” rating and issued a $78.00 price objective on shares of Itron in a report on Friday, July 14th. Guggenheim assumed coverage on shares of Itron in a research note on Tuesday, June 20th. They issued a “buy” rating and a $81.00 target price for the company. Finally, Robert W. Baird downgraded shares of Itron from an “outperform” rating to a “neutral” rating and raised their target price for the company from $73.00 to $77.00 in a research note on Wednesday, July 26th. They noted that the move was a valuation call. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $79.00.

Shares of Itron (NASDAQ:ITRI) traded down 0.48% during mid-day trading on Thursday, hitting $72.05. The company’s stock had a trading volume of 182,334 shares. Itron has a 1-year low of $40.53 and a 1-year high of $75.60. The stock has a market cap of $2.79 billion, a PE ratio of 89.17 and a beta of 1.10. The company has a 50-day moving average price of $70.29 and a 200-day moving average price of $65.06.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Wednesday, August 2nd. The scientific and technical instruments company reported $0.71 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.03. The company had revenue of $503.10 million during the quarter, compared to analysts’ expectations of $491.80 million. Itron had a return on equity of 15.43% and a net margin of 1.60%. Itron’s revenue for the quarter was down 1.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.65 EPS. Analysts predict that Itron will post $3.07 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This article was published by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be accessed at https://stocknewstimes.com/2017/08/06/itron-inc-nasdaqitri-receives-buy-rating-from-needham-company-llc.html.

A number of large investors have recently modified their holdings of the stock. Redwood Investments LLC increased its stake in shares of Itron by 12.2% in the second quarter. Redwood Investments LLC now owns 127,955 shares of the scientific and technical instruments company’s stock valued at $8,669,000 after buying an additional 13,896 shares during the period. Marshall Wace North America L.P. increased its stake in shares of Itron by 48.2% in the second quarter. Marshall Wace North America L.P. now owns 19,962 shares of the scientific and technical instruments company’s stock valued at $1,357,000 after buying an additional 6,495 shares during the period. Everence Capital Management Inc. bought a new stake in shares of Itron during the second quarter valued at about $213,000. KBC Group NV increased its stake in shares of Itron by 1.9% in the second quarter. KBC Group NV now owns 103,010 shares of the scientific and technical instruments company’s stock valued at $6,979,000 after buying an additional 1,907 shares during the period. Finally, BNP Paribas Arbitrage SA increased its stake in shares of Itron by 26.5% in the second quarter. BNP Paribas Arbitrage SA now owns 18,489 shares of the scientific and technical instruments company’s stock valued at $1,253,000 after buying an additional 3,871 shares during the period. Institutional investors and hedge funds own 94.55% of the company’s stock.

Itron Company Profile

Itron, Inc (Itron) is a technology and service company. The Company provides solutions that measure, manage and analyze energy and water use. The Company operates through three segments: Electricity, Gas and Water. It provides a portfolio of products, solutions, software and services to electric, gas and water utility customers across the globe.

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply